EBSAX
Price
$9.86
Change
-$0.01 (-0.10%)
Updated
Jun 6 closing price
Net Assets
2B
MBXIX
Price
$38.50
Change
+$0.45 (+1.18%)
Updated
Jun 6 closing price
Net Assets
8.05B
Interact to see
Advertisement

EBSAX vs MBXIX

Header iconEBSAX vs MBXIX Comparison
Open Charts EBSAX vs MBXIXBanner chart's image
Campbell Systematic Macro A
Price$9.86
Change-$0.01 (-0.10%)
VolumeN/A
Net Assets2B
Catalyst/Millburn Hedge Strategy I
Price$38.50
Change+$0.45 (+1.18%)
VolumeN/A
Net Assets8.05B
EBSAX vs MBXIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EBSAX vs. MBXIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBSAX is a Hold and MBXIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXIX has more cash in the bank: 8.05B vs. EBSAX (2B). MBXIX pays higher dividends than EBSAX: MBXIX (1.92) vs EBSAX (1.20). EBSAX was incepted earlier than MBXIX: EBSAX (12 years) vs MBXIX (9 years). EBSAX (2.09) and MBXIX (2.03) have similar cost to investors . MBXIX is a more actively managed with annual turnover of: 48.00 vs. EBSAX (0.00). EBSAX (2500) and MBXIX (2500) have matching initial minimum investment requirements. EBSAX annual gain was more profitable for investors over the last year : 7.79 vs. MBXIX (-0.35). MBXIX return over 5 years is better than : 52.96 vs. EBSAX (41.36).
EBSAXMBXIXEBSAX / MBXIX
Total Expense Ratio2.002.0399%
Annual Report Gross Expense Ratio2.092.03103%
Fund Existence12 years9 years-
Gain YTD2.386-1.984-120%
Front Load4%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets2B8.05B25%
Annual Yield % from dividends1.201.9263%
Returns for 1 year7.79-0.35-2,244%
Returns for 3 years2.146.9231%
Returns for 5 years41.3652.9678%
Returns for 10 years20.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSACX18.97N/A
N/A
Morgan Stanley Inst Passport ovrs eq I
SBHIX22.84N/A
N/A
Saratoga Health & Biotechnology I
GSMYX23.03N/A
N/A
Goldman Sachs Small/Mid Cap Growth Instl
JLCFX69.60N/A
N/A
JHancock Fundamental Large Cap Core R4
WSCRX33.77N/A
N/A
Allspring Small Company Growth R6